The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
13.53
+0.34 (2.58%)
At close: Oct 30, 2026, 4:00 PM EDT
13.56
+0.03 (0.22%)
After-hours: Oct 30, 2026, 7:56 PM EDT
The Chemours Company Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, The Chemours Company stock has a consensus rating of "Hold" and an average price target of $16.5. The average 1-year stock price forecast is 21.95% higher than the current stock price, while the lowest is $14 (+3.47%) and the highest is $20 (+47.82%).
Price Target: $16.5 (+21.95%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for The Chemours Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 4 | 4 | 4 | 5 | 5 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +47.82% | Oct 20, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Downgrades $18 → $15 | Hold | Downgrades | $18 → $15 | +10.86% | Oct 13, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades $22 → $14 | Hold | Downgrades | $22 → $14 | +3.47% | Oct 13, 2026 |
| Barclays | Barclays | Hold Initiates $16 | Hold | Initiates | $16 | +18.26% | Oct 12, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $18 | Buy | Reiterates | $18 | +33.04% | Oct 5, 2026 |
Financial Forecast
Revenue This Year
5.91B
from 5.81B
Increased by 1.84%
Revenue Next Year
6.20B
from 5.91B
Increased by 4.76%
EPS This Year
0.95
from 0.95
Decreased by -0.20%
EPS Next Year
1.86
from 0.95
Increased by 96.02%
EPS and Forward PE are based on non-GAAP adjusted numbers.